- DNA Repair Deficiency as Circulating Biomarker in Prostate Cancer.
- Roviello G, Generali D, Gatti M, Riboli B, Paganini L, Nesi G, Catalano M.
- Front Oncol. 2023 Jan 12;12:1115241. doi: 10.3389/fonc.2023.1115241.
- Review
- Free Full Text
- Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches.
- Posdzich P, Darr C, Hilser T, Wahl M, Herrmann K, Hadaschik B, Grünwald V.
- Cancers (Basel). 2023 Jan 11;15(2):461. doi: 10.3390/cancers15020461.
- Review
- Free Full Text
- Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse.
- Brouillard-Saby F, Saint-Martin C, Ray-Coquard I, Gladieff L, Pomel C, Colombo PE, Classe JM, Chevrier M, Joly F, De la Motte Rouge T, Floquet A, Sabatier R, Barranger E, Costaz H, Leblanc E, Marchal F, Pautier P, Bosquet L, Rodrigues M.
- Int J Gynecol Cancer. 2023 Jan 11:ijgc-2022-003993. doi: 10.1136/ijgc-2022-003993. Epub ahead of print.
- PMID: 36631150
- PubMed abstract
- Source abstract
- Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.
- Fujita K, Suzuki H, Hinata N, Miura Y, Edamura K, Tabata KI, Arai G, Matsubara N, Yasumizu Y, Kosaka T, Oya M, Sugimoto M.
- Transl Androl Urol. 2022 Dec;11(12):1771-1785. doi: 10.21037/tau-22-396.
- PMID: 36632151
- PubMed abstract
•• Commentary:
Assessment of real-world application of advanced prostate cancer management in Japan.
- PMID: 36632149
- PubMed abstract
- Free Full Text